You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 11, November 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE AMERICAN SOCIETY OF HEAD AND NECK SURGERY, PALM BEACH, FLA, APRIL 30-MAY 1, 1990
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Photodynamic Therapy in the Treatment of Squamous Cell Carcinoma of the Head and Neck

Barry L. Wenig, MD; Daniel M. Kurtzman, MD; Leonard I. Grossweiner, PhD; Mahmood F. Mafee, MD; David M. Harris, PhD; Rocco V. Lobraico, MD; Robert A. Prycz, RN; Edward L. Appelbaum, MD

Arch Otolaryngol Head Neck Surg. 1990;116(11):1267-1270.


Abstract

• Photodynamic therapy is an experimental modality for tumor treatment based on the combined action of the tumor-localizing agent, ie, hematoporphyrin derivative, and red light. From 1985 through 1989, 26 patients were treated using hematoporphyrin-derived drugs and 630-nm light delivered by a tunable dye laser. All patients had biopsy-proved squamous cell carcinoma of the head and neck, and they had either failed the traditional treatment modalities or refused conventional therapies. Histological complete responses were achieved in 20 (77%) of 26 patients and partial responses in 5 (19%) of 26 patients for periods up to 48 months. Only minimal toxic reaction was noted in the group. As a guide to treatment planning for a patient group with large tumors, we used an optical dosimetry model based on tissue optics. The rate of complete responses to this treatment was 8 (73%) of 11. Our data indicate that photodynamic therapy is capable of inducing significant clinical and histological responses in the majority of those treated, and in some patients a prolonged response is produced. In certain select head and neck malignancies, photodynamic therapy has an important role as a treatment modality.

(Arch Otolaryngol Head Neck Surg. 1990;116:1267-1270)



Author Affiliations

From the Departments of Otolaryngology-Head and Neck Surgery (Drs Wenig, Kurtzman, and Appelbaum) and Radiology (Drs Grossweiner, Harris, and Lobraico and Mr Prycz), University of Illinois College of Medicine at Chicago, and the Wenske Laser Center, Ravenswood Hospital (Dr Mafee), Chicago, Ill.


Footnotes

Accepted for publication July 24, 1990.

Read before the American Society for Head and Neck Surgery, Palm Beach, Fla, May 2, 1990.

Reprint requests to Department of Otolaryngology—Head and Neck Surgery, University of Illinois Eye and Ear Infirmary, 1855 W Taylor St, Suite 2.42, Chicago, IL 60612 (Dr Wenig).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Photodynamic Therapy for Head and Neck Dysplasia and Cancer
Rigual et al.
Arch Otolaryngol Head Neck Surg 2009;135:784-788.
ABSTRACT | FULL TEXT  

Photodynamic Therapy in Dentistry
Konopka and Goslinski
JDR 2007;86:694-707.
ABSTRACT | FULL TEXT  

Photodynamic Therapy of Pigmented Choroidal Melanomas Using a Liposomal Preparation of Benzoporphyrin Derivative
Young et al.
Arch Ophthalmol 1996;114:186-192.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.